Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
Weijia Fang, Zhengmao Lu, Jing Ge, Shuangshuang Zhang, Rui Zheng, Weiwei Yin, Ruidong Hao, Minmin Sun, Tianhang Luo
Topics & Concepts
MedicineAdverse effectInternal medicineTargeted therapyCancerGastroenterologyOncologyImmunotherapyRefractory (planetary science)Immune systemClinical trialSurgeryImmunologyAstrobiologyPhysicsCAR-T cell therapy researchVirus-based gene therapy researchImmunotherapy and Immune Responses